United States - English - NLM (National Library of Medicine)

cardinal health - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 100 mg - clozapine tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with their use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)]. the effectiveness of clozapine tablets in treatment-resistant schizophrenia was demonstrated in a 6 week, randomized, double-blind, active-controlled study comparing clozapine tablets and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)]. clozapine tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/he

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozapine tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)]. the effectiveness of clozapine tablets in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)]. clozapine tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinic

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 12.5 mg - clozapine orally disintegrating tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with their use, clozapine orally disintegrating tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)]. the effectiveness of clozapine orally disintegrating tablets in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine orally disintegrating tablets and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)]. clozapine orally disintegrating tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa inc - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 12.5 mg - clozapine odt is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozapine odt should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5 )] . the effectiveness of clozapine in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1 )] . clozapine odt is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - clozapine - tablet - clozapine 25 mg - psycholeptics

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - clozapine - tablet - clozapine 100 mg - psycholeptics

Canada - English - Health Canada

aa pharma inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Canada - English - Health Canada

aa pharma inc - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics

Canada - English - Health Canada

auro pharma inc - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Canada - English - Health Canada

auro pharma inc - clozapine - tablet - 50mg - clozapine 50mg - atypical antipsychotics